英文原著論文
2019年
- 227
- Qian N, Ichimura A, Takei D, Sakaguchi R, Kitani A, Nagaoka R, Tomizawa M, Miyazaki Y, Miyachi H, Numata T, Kakizawa S, Nishi M, Mori Y & Takeshima H.
TRPM7 channels mediate spontaneous Ca2+ fluctuations in growth plate chondrocytes that promote bone development.
Science Signal. 12, eaaw4847. doi: 10.1126/scisignal.aaw4847.
- 225
- Ota W, Nakane Y, Kashio M, Suzuki Y, Nakamura K, Mori Y, Tominaga M & Yoshimura T.
Involvement of TRPM2 and TRPM8 in temperature-dependent masking behavior.
Sci. Rep. 9, 3706 (2019). doi: 10.1038/s41598-019-40067-x.
- 223
- Toda T, Yamamoto S, Umehara N, Mori Y, Wakamori M & Shimizu S.
Protective effects of duloxetine against cerebral ischemia-reperfusion injury via Transient Receptor Potential Melastatin 2 Inhibition.
J. Pharmacol. Exp. Ther. 368, 246-254 (2019). doi: 10.1124/jpet.118.253922.
- 221
- Ohara-Imaizumi M, Aoyagi K, Yamauchi H, Yoshida M, Mori MX, Hida Y, Tran HN, Ohkura M, Abe M, Akimoto Y, Nakamichi Y, Nishiwaki C, Kawakami H, Hara K, Sakimura K, Nagamatsu S, Mori Y, Nakai J, Kakei M & Ohtsuka T.
ELKS/voltage-dependent Ca2+ channel-β subunit module regulates polarized Ca2+ influx in pancreatic β cells.
Cell Rep. 26, 1213-1226 (2019). doi: 10.1016/j.celrep.2018.12.106.
- 220
- Horton JS, Shiraishi T, Alfulaij N, Small-Howard AL, Turner HC, Kurokawa T, Mori Y & Stokes AJ.
TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure.
Channels 1-16 (2019). doi: 10.1080/19336950.2018.1547611.
